At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Apr 2, 2026 at 16:36 ET
Three top executives at United Therapeutics, the CEO, CFO, and General Counsel, sold a combined $376K in shares over a 7-day window, following the exercise of stock options. The sales represent less than 0.0015% of the company's $24.8B market cap and appear to be part of pre-planned, non-discretionary transactions following option exercises.
- CEO Martine Rothblatt sold $21.7K, CFO James Edgemon sold $66.3K, and General Counsel Paul Mahon sold $288K in open-market transactions.
- All sales followed the exercise of stock options, with significant non-cash derivative exercises totaling over $5.4M in option value realized.
- Total dollar value of open-market sales ($376K) is only 0.0015% of the company's $24.8B market cap.
- Sales occurred at prices between $551.86 and $560.30 per share.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access